Financhill
Back

Biogen Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
38

BIIB
Biogen

Last Price:
176.91
Seasonality Move:
5.71%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Biogen Price Quote

$176.91
-0.02 (1.95%)
(Updated: November 6, 2024 at 5:01 AM ET)

Biogen Key Stats

Sell
38
Biogen (BIIB) is a Sell

Day range:
$170.72 - $177.25
52-week range:
$170.71 - $268.30
Dividend yield:
0%
P/E ratio:
22.20
P/S ratio:
2.69
P/B ratio:
1.58%

Volume:
2.5M
Avg. volume:
1.4M
1-year change:
-29.09%
Market cap:
$25.8B
Revenue:
$9.8B
EPS:
$11.07

How Much Does Biogen Make?

  • How Much Are Biogen's Sales Annually?
    BIIB Revenues are $9.8B
  • How Much Profit Does Biogen's Make A Year?
    BIIB net income is $1.2B

Is Biogen Growing As A Company?

  • What Is Biogen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.03%
  • What Is Biogen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Biogen Stock Price Performance

  • Did Biogen Stock Go Up Last Month?
    Biogen share price went down by -4.71% last month
  • Did BIIB's Share Price Rise Over The Last Year?
    BIIB share price fell by -29.09% over the past 1 year

What Is Biogen 52-Week High & Low?

  • What Is Biogen’s 52-Week High Share Price?
    Biogen has traded as high as $268.30 over the past 52 weeks
  • What Is Biogen’s 52-Week Low Share Price?
    Biogen has traded as low as $170.71 over the past 52 weeks

Biogen Price To Free Cash Flow

  • Is Biogen Stock Overvalued?
    Biogen is trading at a price to free cash flow ratio of 14.60
  • Is Biogen Stock Undervalued?
    Biogen EV to Free Cash Flow ratio is 17.18
  • What Is Biogen’s Price Earnings Growth Ratio?
    BIIB PEG ratio is 1.59
  • Is Biogen Trading At A Premium To Earnings?
    Biogen EV to EBIT ratio is 14.01

Is It Risky To Buy Biogen?

  • How Much Debt Does Biogen Have?
    Total long term debt quarterly is $6.3B
  • How Much Cash Does Biogen Have?
    Cash and short term investments quarterly total is $1.7B
  • What Is Biogen’s Book Value Per Share?
    Book value per share is 112.28

Is Biogen Cash Flow Positive?

  • What Is BIIB Cash Flow From Operations?
    Cash flow from operations (TTM) is $2.1B
  • What Is Biogen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is Biogen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.4B

Biogen Return On Invested Capital

  • Is Management Doing A Good Job?
    BIIB return on invested capital is 7.34%
  • What Is Biogen Return On Assets?
    ROA measures how assets are converting to revenues and is 5.91%
  • What Is BIIB Return On Equity?
    ROE is a measure of profitability and is 10.52%

Biogen Earnings Date & Stock Price

  • What Is Biogen's Stock Price Today?
    A single share of BIIB can be purchased today for 176.93
  • What Is Biogen’s Stock Symbol?
    Biogen trades on the S&P500 under the ticker symbol: BIIB
  • When Is Biogen’s Next Earnings Date?
    The next quarterly earnings date for Biogen is scheduled on November 8, 2024
  • When Is BIIB's next ex-dividend date?
    Biogen's next ex-dividend date is June 18, 2020
  • How To Buy Biogen Stock?
    You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biogen Competitors

  • Who Are Biogen's Competitors?
    Below is a list of companies who compete with Biogen or are related in some way:
    • Ionis Pharmaceuticals Inc (IONS)
    • Eli Lilly and Co (LLY)
    • Moderna Inc (MRNA)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Sage Therapeutics Inc (SAGE)

Biogen Dividend Yield

  • What Is BIIB Dividend Yield?
    Biogen’s dividend yield currently is 0%
  • What Is Biogen’s Payout Ratio?
    Biogen’s payout ratio is 0%
  • When Did Biogen Last Pay A Dividend?
    The latest dividend pay date is November 6, 2024
  • What Is Biogen’s Dividend Per Share?
    Biogen pays a dividend of $0.00 per share

Biogen Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.79%
Revenue: -2.55% 1.28%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 10
Sell Recommendations: 0
Price Target: 252.94
Upside from Last Price: 42.96%

Major Shareholders

  • How many BIIB shares are owned by institutional investors?
    188.3M BIIB shares are owned by institutional investors
  • How many BIIB shares are owned by insiders?
    2.2M BIIB shares are owned by insiders